The Enterprise Value as of November 2024 (TTM) for Novozymes A/S (NVZMY) is 211.48B

According to Novozymes A/S’s latest financial reports and current stock price. The company's current Enterprise Value is 211.48B. This represents a change of 94.15% compared to the average of 108.93B of the last 4 quarters.

Novozymes A/S (NVZMY) Historical Enterprise Value (quarterly & annually)

How has NVZMY Enterprise Value performed in the past?

The mean historical Enterprise Value of Novozymes A/S over the last ten years is 99.38B. The current 211.48B Enterprise Value has changed 21.18% with respect to the historical average. Over the past ten years (40 quarters), NVZMY's Enterprise Value was at its highest in in the December 2021 quarter at 150.09B. The Enterprise Value was at its lowest in in the December 2016 quarter at 74.04B.

Novozymes A/S (NVZMY) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Novozymes A/S Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Novozymes A/S (NVZMY) Average Enterprise Value

How has NVZMY Enterprise Value performed in the past?

The current Enterprise Value of Novozymes A/S (NVZMY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Novozymes A/S (NVZMY) Enterprise Value vs. Peers

How is NVZMY’s Enterprise Value compared to its peers?

Novozymes A/S’s Enterprise Value is greater than L'Air Liquide S.A. (104.99B), greater than PPG Industries, Inc. (34.19B), greater than The Sherwin-Williams Company (104.20B), greater than Air Products and Chemicals, Inc. (80.34B), less than Sika AG (0), greater than International Flavors & Fragrances Inc. (43.56B), greater than Livent Corporation (34.72B), greater than Albemarle Corporation (3.10B), greater than Sika AG (13.65B), greater than Givaudan SA (44.00B), greater than Symrise AG (42.32B), greater than Givaudan SA (17.36B), greater than null (45.78B),

Build a custom stock screener for Novozymes A/S (NVZMY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novozymes A/S using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Novozymes A/S (NVZMY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Novozymes A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.